Table 3.
Liver Function Tests | |||
---|---|---|---|
Groups | Total Bilirubin [mg/dl] | Aspartate Transaminase (AST) [U/l] | Alanine Transaminase (ALT) [U/l] |
NC | 3.43 ± 0.40 | 120.67 ± 1.53 | 36.00 ± 2.00 |
CC | 2.13 ± 0.95 | 214.67 ± 1.53 * | 53.67 ± 1.53 |
CT | 5.27 ± 0.59 | 265.00 ± 2.00 * | 95.67 ± 1.53 * |
NDV8 | 4.43 ± 0.40 | 153.33 ± 1.53 | 38.67 ± 1.53 |
NDV16 | 5.75 ± 0.35 | 125.33 ± 93.82 | 41.67 ± 1.53 |
NDV32 | 4.87 ± 0.35 | 105.00 ± 1.00 | 47.00 ± 1.00 |
NDV64 | 5.13 ± 0.67 | 115.00 ± 11.27 | 52.67 ± 2.51 |
CNDV8 | 4.47 ± 0.35 | 98.67 ± 1.53 | 26.33 ± 1.15 |
CNDV16 | 3.00 ± 0.50 | 173.33 ± 1.53 | 57.00 ± 1.00 |
CNDV32 | 2.87 ± 0.35 | 121.00 ± 2.00 | 49.00 ± 1.00 |
CNDV64 | 3.40 ± 0.40 | 153.67 ± 1.53 | 49.33 ± 0.58 |
CNDV8 + T | 2.77 ± 0.45 | 166.67 ± 56.62 | 103.00 ± 2.00 * |
CNDV16 + T | 2.43 ± 0.40 | 108.00 ± 1.00 | 56.33 ± 1.53 |
CNDV32 + T | 10.67 ± 4.72 * | 122.33 ± 2.52 | 160.33 ± 25.66 * |
CNDV64 + T | 14.33 ± 4.04 * | 170.67 ± 1.53 | 146.33 ± 32.52 * |
NC normal control, CC cancer contro; CT allotransplanted + Tamoxifen, NDV virus alone; CNDV, allotransplanted + virus; CNDV + T, allotransplanted + virus + Tamoxifen; n = 6. Data are shown as mean ± S.D. *p < 0.05 compared with NC